CSL is launching a new product line for the next generation of smart home devices.
Published
Signal category
Strategy & Corporate Development
Quote
“CSL is launching a new product line for the next generation of smart home devices”
— William Maung Tay, Ph.D.|CSL team
Company
- Industry
- Biotechnology Research
- Location
- Melbourne, AU
- Company size
- 23,117 employees
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra